SEC Form 4 · accession 0001209191-16-088037
ADURO BIOTECH, INC. · ADRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen T Isaacs
Officer — President and CEO · Director
Period of report
Dec 31, 2015
Accepted (ET)
Jan 4, 2016 · 7:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001435049
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 31, 2015 | M | 10,000 | $0.45 | A | 10,000 | D | |
| Common StockF1 | holding | — | — | — | 156,157 | I | By Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $0.45 | Dec 31, 2015 | M | 10,000 | D | — | Mar 18, 2020 | Common Stock | 10,000 | 26,532 | D |
Explanation of responses
- F1The shares are owned directly by the Isaacs-MacBride Family Trust UAD 03/09/01, for which the Reporting Person is a trustee.
- F2The shares subject to the Option are fully vested and immediately exercisable.